Infectious Disease Alert – March 15, 2003

March 15, 2003

• Tenofovir in HIV/HBV-Coinfected Patients

  Tenofovir effectively reduces HBV replication over 24 weeks of therapy in HIV-coinfected patients.

  Read more about Tenofovir in HIV/HBV-Coinfected Patients - Infectious Disease Alert – March 15, 2003

• Getting the Bugs Out of Bronchoscopes

  Bacterial contamination of bronchoscopes, resulting in both unnecessary antibiotic use and clinical infection, resulted from a change in design of the instruments.

  Read more about Getting the Bugs Out of Bronchoscopes - Infectious Disease Alert – March 15, 2003

• Outpatient Antibiotic Use — France vs Germany: A Cultural Lesson

  The French use antibiotics quite differently from the Germans, for a variety of reasons, including cultural factors and regulations, in addition to physician habits and patient expectations.

  Read more about Outpatient Antibiotic Use — France vs Germany: A Cultural Lesson - Infectious Disease Alert – March 15, 2003

• More on MRSA: Long-Term Risk of Infection Following Acquisition

  Twenty-nine percent of patients newly identified as carrying MRSA will have subsequent MRSA infection over the following 18 months.

  Read more about More on MRSA: Long-Term Risk of Infection Following Acquisition - Infectious Disease Alert – March 15, 2003

• Antibiotic Susceptibility of Bacteroides fragilis Group Organisms

  Metronidazole, piperacillin/tazobactam, and the carbapenems remain the most reliably active against B fragilis group organisms.

  Read more about Antibiotic Susceptibility of <I>Bacteroides fragilis</I> Group Organisms - Infectious Disease Alert – March 15, 2003

• Updates by Carol A. Kemper, MD, FACP

  Updates

  Read more about Updates by Carol A. Kemper, MD, FACP - Infectious Disease Alert – March 15, 2003